220 related articles for article (PubMed ID: 6778611)
1. Excretion of an aflatoxin-guanine adduct in the urine of aflatoxin B1-treated rats.
Bennett RA; Essigmann JM; Wogan GN
Cancer Res; 1981 Feb; 41(2):650-4. PubMed ID: 6778611
[TBL] [Abstract][Full Text] [Related]
2. Molecular dosimetry in rat urine of aflatoxin-N7-guanine and other aflatoxin metabolites by multiple monoclonal antibody affinity chromatography and immunoaffinity/high performance liquid chromatography.
Groopman JD; Hasler JA; Trudel LJ; Pikul A; Donahue PR; Wogan GN
Cancer Res; 1992 Jan; 52(2):267-74. PubMed ID: 1728400
[TBL] [Abstract][Full Text] [Related]
3. Quantification and validation of enzyme immunoassay for urinary aflatoxin B1-N7-guanine adduct for biological monitoring of aflatoxins.
Nayak S; Sashidhar RB; Bhat RV
Analyst; 2001 Feb; 126(2):179-83. PubMed ID: 11235100
[TBL] [Abstract][Full Text] [Related]
4. Direct synthesis of aflatoxin B1-N7 guanine adduct: a reference standard for biological monitoring of dietary aflatoxin exposure in molecular epidemiological studies.
Vidyasagar T; Sujatha N; Sashidhar RB
Food Addit Contam; 1997 Jul; 14(5):457-67. PubMed ID: 9328530
[TBL] [Abstract][Full Text] [Related]
5. Identification of the principal aflatoxin B1-DNA adduct formed in vivo in rat liver.
Croy RG; Essigmann JM; Reinhold VN; Wogan GN
Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1745-9. PubMed ID: 273905
[TBL] [Abstract][Full Text] [Related]
6. Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro.
Essigmann JM; Croy RG; Nadzan AM; Busby WF; Reinhold VN; Büchi G; Wogan GN
Proc Natl Acad Sci U S A; 1977 May; 74(5):1870-4. PubMed ID: 266709
[TBL] [Abstract][Full Text] [Related]
7. In vitro reactions of aflatoxin B1-adducted DNA.
Groopman JD; Croy RG; Wogan GN
Proc Natl Acad Sci U S A; 1981 Sep; 78(9):5445-9. PubMed ID: 6795633
[TBL] [Abstract][Full Text] [Related]
8. Detection of putative adduct with fluorescence characteristics identical to 2,3-dihydro-2-(7'-guanyl)-3-hydroxyaflatoxin B1 in human urine collected in Murang'a district, Kenya.
Autrup H; Bradley KA; Shamsuddin AK; Wakhisi J; Wasunna A
Carcinogenesis; 1983 Sep; 4(9):1193-5. PubMed ID: 6411378
[TBL] [Abstract][Full Text] [Related]
9. Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases.
Kensler TW; Egner PA; Davidson NE; Roebuck BD; Pikul A; Groopman JD
Cancer Res; 1986 Aug; 46(8):3924-31. PubMed ID: 2873884
[TBL] [Abstract][Full Text] [Related]
10. Structural characterization of the major adducts obtained after reaction of an ultimate carcinogen aflatoxin B1-dichloride with calf thymus DNA in vitro.
Wood ML; Smith JR; Garner RC
Cancer Res; 1988 Oct; 48(19):5391-6. PubMed ID: 3138022
[TBL] [Abstract][Full Text] [Related]
11. Mutational properties of the primary aflatoxin B1-DNA adduct.
Bailey EA; Iyer RS; Stone MP; Harris TM; Essigmann JM
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1535-9. PubMed ID: 8643667
[TBL] [Abstract][Full Text] [Related]
12. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts.
Yu MW; Lien JP; Liaw YF; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):613-9. PubMed ID: 8824363
[TBL] [Abstract][Full Text] [Related]
13. Aflatoxin B1 mutagenesis, DNA binding, and adduct formation in Salmonella typhimurium.
Stark AA; Essigmann JM; Demain AL; Skopek TR; Wogan GN
Proc Natl Acad Sci U S A; 1979 Mar; 76(3):1343-7. PubMed ID: 375236
[TBL] [Abstract][Full Text] [Related]
14. Detection of 8,9-dihydro-(7'-guanyl)-9-hydroxyaflatoxin B1 in human urine.
Autrup H; Wakhisi J; Vahakangas K; Wasunna A; Harris CC
Environ Health Perspect; 1985 Oct; 62():105-8. PubMed ID: 3936705
[TBL] [Abstract][Full Text] [Related]
15. Aflatoxin B1 carcinogenesis and its relation to DNA adduct formation and adduct persistence in sensitive and resistant salmonid fish.
Bailey GS; Williams DE; Wilcox JS; Loveland PM; Coulombe RA; Hendricks JD
Carcinogenesis; 1988 Nov; 9(11):1919-26. PubMed ID: 3141073
[TBL] [Abstract][Full Text] [Related]
16. Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa.
Groopman JD; Hall AJ; Whittle H; Hudson GJ; Wogan GN; Montesano R; Wild CP
Cancer Epidemiol Biomarkers Prev; 1992; 1(3):221-7. PubMed ID: 1339082
[TBL] [Abstract][Full Text] [Related]
17. Comparative formation and removal of aflatoxin B1-DNA adducts in cultured mammalian tracheal epithelium.
Ball RW; Wilson DW; Coulombe RA
Cancer Res; 1990 Aug; 50(16):4918-22. PubMed ID: 2116221
[TBL] [Abstract][Full Text] [Related]
18. Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry.
Roebuck BD; Liu YL; Rogers AE; Groopman JD; Kensler TW
Cancer Res; 1991 Oct; 51(20):5501-6. PubMed ID: 1680553
[TBL] [Abstract][Full Text] [Related]
19. Aflatoxin metabolism in humans: detection of metabolites and nucleic acid adducts in urine by affinity chromatography.
Groopman JD; Donahue PR; Zhu JQ; Chen JS; Wogan GN
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6492-6. PubMed ID: 3931076
[TBL] [Abstract][Full Text] [Related]
20. Quantitative and qualitative characterization of aflatoxin B1 adducts formed in vivo within the ribosomal RNA genes of rat liver DNA.
Irvin TR; Wogan GN
Cancer Res; 1985 Aug; 45(8):3497-502. PubMed ID: 3926300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
